BADM LIMITED LIABILITY COMPANY TRADE DATA ANALYSIS
Access comprehensive trade data for Badm Limited Liability Company with ease. Explore trade shipments, top suppliers & buyers, and values without the hassle.
Badm Limited Liability Company – Overview
Eximpedia analyzes Badm Limited Liability Company export and import records, including data from 0 buyers and 134 suppliers. We provide an intelligence report of Badm Limited Liability Company that covers trade statistics, shipment values, quantities, exporters & importers and trade destinations
Badm Limited Liability Company Buyers, Suppliers & Shipments
Badm Limited Liability Company import markets
Explore the Badm Limited Liability Company import market with monthly import values, major importers, HS Codes, key ports, top suppliers, and competitors
TOP IMPORT HS CODE
| HS CODE | USD VALUE | SHIPMENTS | % |
|---|---|---|---|
| 3004900000 | 197.37 | 2330 | 45.10 |
| MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
| 3004320000 | 19.30 | 351 | 6.79 |
| MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
| 3004500000 | 16.18 | 258 | 4.99 |
| MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
| 3004200000 | 13.17 | 392 | 7.59 |
| MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
| 3004490000 | 11.31 | 228 | 4.41 |
| MEDICAMENTS (EXCLUDING GOODS OF HEADING 3002, 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC USES, PUT UP IN MEASURED DOSES (IINCLUDING THOSE IN THE FORM OF TRANSDERMAL ADMINISTRATION SYSTEMS) OR IN FORMS OR PACKINGS | |||
TOP IMPORT COUNTRY
| COUNTRY | USD VALUE | SHIPMENTS | % |
|---|---|---|---|
| GERMANY | 70.91 | 648 | 12.54 |
| ITALY | 29.92 | 373 | 7.22 |
| SLOVENIA | 26.30 | 264 | 5.11 |
| HUNGARY | 19.65 | 287 | 5.56 |
| EUROPEAN UNION | 19.16 | 572 | 11.07 |
TOP IMPORT PORTS
| PORT NAME | USD VALUE | SHIPMENTS | % |
|---|---|---|---|
| UA100200 | 142.55 | 2923 | 56.58 |
| UA110130 | 80.12 | 1159 | 22.44 |
| UA110170 | 33.15 | 393 | 7.61 |
| UA209140 | 46.78 | 366 | 7.08 |
| UA100110 | 5.31 | 325 | 6.29 |
TOP IMPORT COMPETITORS
| COMPANY | USD VALUE | SHIPMENTS |
|---|---|---|
| MINISTRY OF HEALTH | 206.51 | 8344 |
| SOCIAL SECURITY INSTITUTION | 231.08 | 35 |
| BADM LIMITED LIABILITY COMPANY | 394.73 | 5166 |
| JV OPTIMA FARM LIMITED | 400.43 | 5786 |
| TURKISH PHARMACISTS ASSOCIATION ECONOMIC ENTERPRISE | 536.15 | 2196 |
TOP IMPORT SUPPLIERS
| COMPANY | USD VALUE | SHIPMENTS |
|---|---|---|
| TANNER PHARMA CH GMBH ON BEHALF OF MAXAID | 117.29 | 15 |
| BIOGEN INTERNATIONAL GMBH | 127.48 | 115 |
| BOEHRINGER INGELHEIM | 146.49 | 839 |
| BMED INTERNATIONAL BUSINESS COMPANY LIMITED | 150.27 | 163 |
| GEN ILAÇ INTERNATIONAL TRADING LIMITED | 244.44 | 236 |
If you are looking to establish relationship with Badm Limited Liability Company Automation you can save time by getting access to the key decision makers and get a detailed report.
Badm Limited Liability Company Import Shipments
Discover the Badm Limited Liability Company with product description, import values, quantities, exporter name, country of origin and key destinations.
| HSN Code | Product Description | Imports | Exporter | Origin | Destination | Qty. |
|---|---|---|---|---|---|---|
| 3004200000 | 1. MEDICINE FOR HUMANS CONTAINING ANTIBIOTICS, NOT IN AEROSOLS: FROMILIDE ® GRANULES FOR PREPARATION OF ORAL SUSPENSION 60ML (250MG/5ML), 1 VIAL WITH GRANULES AND 1 SPRAY Ц FOR ORAL ADMINISTRATION OF SUSPENSION IN A CARTON BOX / 5 ML OF SUSPENSION (1 SYRINGE) CONTAINS 250 MG OF CLARITROMYCIN; MANUFACTURER KRKA, D.D., NOVO MESTO (SECONDARY PACKAGING, BATCH CONTROL AND BATCH RELEASE) / KRKA, D.D., NOVO MESTO (""IN BULK"" PRODUCTION, PRIMARY AND SECONDARY PACKAGING) / KRKA, D.D |  |
|
SLOVENIA | UKRAINE | 0 |
| 3004320000 | 1. DRUGS FOR HUMANS CONTAINING CORTICOSTEROID HORMONES, PACKAGED FOR RETAIL TRADE, NOT IN AEROSOL PACKAGING: KENALOG 40, SUSPENSION FOR INJECTION, 40 MG/ML, 1 ML IN AMPOULE; 5 AMPOULES IN BLISTERS; 1 BLISTER IN A CARDBOARD BOX / 1 ML OF SUSPENSION FOR INJECTION CONTAINS TRIAMCINOLON ACETONIDE 40 MG; MANUFACTURER KRKA, D.D., NOVO MESO, SLOVENIA | |
|
SLOVENIA | UKRAINE | 0 |
| 3004500000 | 1. MEDICINE FOR HUMANS CONTAINING VITAMINS, FOR RETAIL SALE, NOT IN AEROSOL PACKAGING: DUOVIT ® , COATED TABLETS, COMBI PACKAGING: 5 RED TABLETS + 5 BLUE TABLETS IN BLISTERS; 4 BLISTERS IN A CARDBOARD BOX / 1 RED TABLET: VITAMINS: A (IN THE FORM OF RETINOL PALMITATE) - 5000 IU, CHOLICALCIPHEROL (VITAMIN D3) - 200 IU, ASCORBIC ACID (VITAMIN C) - 60 MG, THIAMINE NITRATE (VITAMIN B1) - 1 MG; RIBOFLAVIN (VITAMIN B2) - 1.2 MG; PYRIDOXINE HYDROCHLORIDE (VITAMIN B6) - 2 MG; CYANOCOBALAMIN (VITAMIN B12) - 3 MCG; NICOTINAMIDE 13 MG; FOLIC ACID 0.4 MG; CALCIUM PANTOTHENATE 5 MG; A-TOCOPHEROL ACETATE (VITAMIN E) - 10 MG; 1 TABLET OF BLUE COLOR: CALCIUM (CA) IN THE FORM OF CALCIUM HYDROPHOSPHATE) - 15 MG, PHOSPHORUS (P) IN THE FORM OF CALCIUM HYDROPHOSPHATE) - 12 MG, IRON (FE) IN THE FORM OF IRON FURMATE) - 10 MG, COPPER (CU) IN THE FORM OF COPPER SULFATE) - 1 MG, ZINC (ZN) IN THE FORM OF ZINC SULFATE) - 3 MG, MAGNESIUM (MG) IN THE FORM OF MAGNESIUM LACTATE) - 20 MG; MANGANESE (MN) IN THE FORM OF MANGANESE SULFATE) - 1 MG, MOLYBDENUM (MO) IN THE FORM OF SODIUM MOLYBDATE) - 0.1 MG; MANUFACTURER KRKA, D.D., NOVO MESTO (BATCH CONTROL AND RELEASE) / KRKA, D.D., NOVO MESTO (MANUFACTURING """"IN BULK"""", PRIMARY PACKAGING, SECONDARY PACKAGING, BATCH CONTROL) / KRKA, D.D. ., NOVO MESO (SERIES CONTROL), SLOVENIA/NLZOH (NATIONAL LABORATORIES FOR HEALTH, ENVIRONMENT AND HRANO) (SERIES CONTROL), SLOVENIA | |
|
SLOVENIA | UKRAINE | 0 |
| 3004900000 | 1. DRUGS FOR HUMANS, WITHOUT CONTENT: VITAMINS, HORMONES, ALKALOIDS, ANTIBIOTICS, FOR RETAIL TRADE, NOT IN AEROSOL PACKAGING: AMLESSA, TABLETS, 4 MG/5 MG OF 10 TABLETS IN BLISTERS; 3 BLISTERS IN A CARDBOARD BOX / 1 TABLET CONTAINS 4 MG PERINDOPRIL TERT-BUTYLAMINE (EQUIVALENT TO 3.34 MG PERINDOPRIL) AND 5 MG AMLODIPINE (EQUIVALENT TO 6.935 MG AMLODIPINE BESYLATE); MANUFACTURER KRKA, D.D., NOVO MESTO (MANUFACTURING """"IN BULK"""", PRIMARY AND SECONDARY PACKAGING, BATCH CONTROL AND RELEASE), SLOVENIA/KRKA, D.D., NOVO MESTO (BATCH CONTROL (PHYSICAL AND CHEMICAL CONTROL METHODS )), SLOVENIA; CO-AMLESSA, TABLETS, 4 MG/1.25 MG/5 MG 10 TABLETS IN BLISTERS; 3 BLISTERS IN A CARDBOARD BOX / 1 TABLET CONTAINS: 4 MG OF PERINDOPRIL TERT-BUTYLAMINE, 1.25 MG OF INDAPAMIDE AND 5 MG OF AMLODIPINE (AS AMLODIPINE BESYLATE); MANUFACTURER KRKA, D.D., NOVO MESTO (MANUFACTURING """"IN BULK"""", PRIMARY AND SECONDARY PACKAGING, BATCH CONTROL, BATCH RELEASE)/KRKA, D.D., NOVO MESTO (PRIMARY AND SECONDARY PACKAGING)/KRKA, D .D., NOWO MESO (SERIES CONTROL), SLOVENIA/KRKA, POLAND SP.Z.O.O. (PRIMARY AND SECONDARY PACKAGING, BATCH CONTROL, BATCH RELEASE), POLAND/TAD PHARMA GMBH (PRIMARY AND SECONDARY PACKAGING, BATCH CONTROL, BATCH RELEASE), GERMANY/LS CE & CO. LABORATORY. KG (CONTROL OF MICROBIOLOGICAL PURITY OF THE SERIES (IN THE CASE OF SERIES CONTROL OF TAD PHARMA GMBH)), GERMANY; KO-AMLESSA, TABLETS, 8 MG/2.5 MG/5 MG OF 10 TABLETS IN BLISTERS; 3 BLISTERS IN A CARDBOARD BOX / 1 TABLET CONTAINS: 8 MG PERINDOPRIL TERT-BUTYLAMINE, 2.5 MG INDAPAMIDE AND 5 MG AMLODIPINE (AS AMLODIPINE BESYLATE); MANUFACTURER KRKA, D.D., NOVO MESTO (MANUFACTURING """"IN BULK"""", PRIMARY AND SECONDARY PACKAGING, BATCH CONTROL, BATCH RELEASE)/KRKA, D.D., NOVO MESTO (PRIMARY AND SECONDARY PACKAGING)/KRKA, D .D., NOWO MESO (SERIES CONTROL), SLOVENIA/KRKA, POLAND SP.Z.O.O. (PRIMARY AND SECONDARY PACKAGING, BATCH CONTROL, BATCH RELEASE), POLAND/TAD PHARMA GMBH (PRIMARY AND SECONDARY PACKAGING, BATCH CONTROL, BATCH RELEASE), GERMANY/LS CE & CO. LABORATORY. KG (CONTROL OF MICROBIOLOGICAL PURITY OF THE SERIES (IN THE CASE OF SERIES CONTROL OF TAD PHARMA GMBH)), GERMANY; KO-AMLESSA, TABLETS, 8 MG/2.5 MG/10 MG OF 10 TABLETS IN A BLISTER; 3 BLISTERS IN A CARDBOARD BOX / 1 TABLET CONTAINS: 8 MG PERINDOPRIL TERT-BUTYLAMINE, 2.5 MG INDAPAMIDE AND 10 MG AMLODIPINE (AS AMLODIPINE BESYLATE); MANUFACTURER KRKA, D.D., NOVO MESTO (MANUFACTURING """"IN BULK"""", PRIMARY AND SECONDARY PACKAGING, BATCH CONTROL, BATCH RELEASE)/KRKA, D.D., NOVO MESTO (PRIMARY AND SECONDARY PACKAGING)/KRKA, D .D., NOWO MESO (SERIES CONTROL), SLOVENIA/KRKA, POLAND SP.Z.O.O. (PRIMARY AND SECONDARY PACKAGING, BATCH CONTROL, BATCH RELEASE), POLAND/TAD PHARMA GMBH (PRIMARY AND SECONDARY PACKAGING, BATCH CONTROL, BATCH RELEASE), GERMANY/LS CE & CO. LABORATORY. KG (CONTROL OF MICROBIOLOGICAL PURITY OF THE BATCH (IN THE CASE OF BATCH CONTROL OF TAD PHARMA GMBH)), GERMANY; ATORIS ®, FILM-COATED TABLETS, 10 MG OF 10 TABLETS IN A BLISTER; 3 BLISTERS IN A CARDBOARD BOX / 1 FILM-COATED TABLET CONTAINS 10 MG OF ATORVASTATIN AS ATORVASTATIN CALCIUM; MANUFACTURER KRKA, D.D., NOVO MESO (MANUFACTURING """"IN BULK"""", PRIMARY AND SECONDARY PACKAGING, BATCH CONTROL AND BATCH RELEASE)/KRKA, D.D., NOVO MESO (BATCH CONTROL), SLOVENIA/KEMILAB D. O.O. (LOT CONTROL), SLOVENIA; ATORIS ®, FILM-COATED TABLETS, 20 MG, 10 TABLETS IN BLISTERS; 3 BLISTERS IN A CARDBOARD BOX / 1 FILM-COATED TABLET CONTAINS 20 MG OF ATORVASTATIN AS ATORVASTATIN CALCIUM; MANUFACTURER KRKA, D.D., NOVO MESO (MANUFACTURING """"IN BULK"""", PRIMARY AND SECONDARY PACKAGING, BATCH CONTROL AND BATCH RELEASE)/KRKA, D.D., NOVO MESO (BATCH CONTROL), SLOVENIA/KEMILAB D. O.O. (LOT CONTROL), SLOVENIA; ATORIS ®, FILM-COATED TABLETS, 20 MG, 10 TABLETS IN BLISTERS; 9 BLISTERS IN A CARDBOARD BOX / 1 FILM-COATED TABLET CONTAINS 20 MG OF ATORVASTATIN AS ATORVASTATIN CALCIUM; MANUFACTURER KRKA, D.D., NOVO MESO (""IN BULK"" PRODUCTION, PRIMARY AND SECONDARY) | |
|
SLOVENIA | UKRAINE | 0 |
| 3004900000 | 1. DRUGS FOR HUMANS, WITHOUT CONTENTS: VITAMINS, HORMONES, ALKALOIDS, ANTIBIOTICS, FOR RETAIL TRADE, NOT IN AEROSOL PACKAGING: ZALASTA ®, 10 MG TABLETS, 7 TABLETS IN BLISTERS; 4 BLISTERS IN A CARDBOARD BOX / 1 TABLET CONTAINS OLANZAPINE 10 MG; MANUFACTURER KRKA, D.D., NOWO MESO, SLOVENIA/KRKA, POLAND SP.Z.O.O., POLAND | |
|
POLAND | UKRAINE | 0 |
| 3004900000 | 1. DRUGS FOR HUMANS, WITHOUT CONTENTS: VITAMINS, HORMONES, ALKALOIDS, ANTIBIOTICS, FOR RETAIL TRADE, NOT IN AEROSOL PACKAGING: NOLPAZ ®, LYOPHILISATE FOR SOLUTION FOR INJECTIONS, 1 VIAL WITH LYOPHILISATE IN A CARTON ONE BOX / 1 BOTTLE CONTAINS PANTOPRAZOLE 40 MG (AS PANTOPRAZOLE SODIUM SESQUIHYDRATE); MANUFACTURER VALDEPHARM (PRODUCTION OF UNPACKAGED ""BULK"" PRODUCTS, PRIMARY AND SECONDARY PACKAGING, BATCH CONTROL), FRANCE/SOFARIMEX-INDUSTRIA QUIMICA E PHARMACEVTICA, S.A. (PRODUCTION OF UNPACKAGED ""BULK"" PRODUCTS, PRIMARY AND SECONDARY PACKAGING), PORTUGAL/KRKA, D.D., NOVO MESO (SECONDARY PACKAGING, BATCH CONTROL AND BATCH RELEASE), SLOVENIA/LABORATORIOS ALKALA FARMA, S.L. (PRODUCTION OF UNPACKAGED ""BULK"" PRODUCTS, PRIMARY AND SECONDARY PACKAGING), SPAIN | |
|
PORTUGAL | UKRAINE | 0 |
| 3004500000 | 1. MEDICINES FOR HUMANS CONTAINING VITAMINS, FOR RETAIL TRADE, NOT IN AEROSOL PACKAGING: VAZILIP ®, FILM-COATED TABLETS, 40 MG, 7 TABLETS IN BLISTERS; 4 BLISTERS IN A CARDBOARD BOX / 1 FILM-COATED TABLET CONTAINS 40 MG SIMVSTATIN; MANUFACTURER KRKA, D.D., NOVO MESTO (""IN BULK"" MANUFACTURING, PRIMARY AND SECONDARY PACKAGING, BATCH CONTROL AND RELEASE) / KRKA, D.D., NOVO MESTO (BATCH CONTROL), SLOVENIA/LABENA D.O.O. (SERIES CONTROL), SLOVENIA | |
|
SLOVENIA | UKRAINE | 0 |
| 3004900000 | 1. DRUGS FOR HUMANS, WITHOUT CONTENTS: VITAMINS, HORMONES, ALKALOIDS, ANTIBIOTICS, FOR RETAIL TRADE, NOT IN AEROSOL PACKAGING: TORENDO ® FILM-COATED TABLETS, 4 MG, 10 TABLETS IN BLISTER 3 BLISTERS IN A CARTON BOXES / 1 FILM-COATED TABLET CONTAINS 4 MG RISPERIDONE; MANUFACTURER KRKA, D.D., NOVO MESO (""IN BULK"" MANUFACTURING, PRIMARY AND SECONDARY PACKAGING, BATCH CONTROL AND BATCH RELEASE) / KRKA, D.D., NOVO MESO (BATCH CONTROL), SLOVENIA; TORENDO ®, TABLETS, FILM-COATED, 4 MG, 10 TABLETS IN BLISTERS, 6 BLISTERS IN CARDBOARD BOX / 1 FILM-COATED TABLET CONTAINS 4 MG RISPERIDONE; MANUFACTURER KRKA, D.D., NOVO MESTO (""IN BULK"" MANUFACTURING, PRIMARY AND SECONDARY PACKAGING, BATCH CONTROL AND BATCH RELEASE) / KRKA, D.D., NOVO MESTO (BATCH CONTROL), SLOVENIA | |
|
SLOVENIA | UKRAINE | 0 |
| 2106909200 | 1. DIETARY SUPPLEMENTS FOR HUMANS (BIOLOGICALLY ACTIVE FOOD SUPPLEMENTS) THAT DO NOT CONTAIN ALCOHOL, COMPONENTS OF ANIMAL ORIGIN, WITHOUT DAIRY FATS, SUCROSE, ISOGLUCOSE, GLUCOSE, STARCH, NOT IN AEROSOL PACKAGING: HERBION® SYRUP ICELAND MOSS, SYRUP, 6 MG/ML OF 150 ML IN A VIAL; 1 VIAL WITH MEASURING SPOON IN A CARDBOARD BOX / 1 ML OF SYRUP CONTAINS 6 MG OF THICK EXTRACT OF ICELAND MOSS (CETRARIA ISLANDICA (L.) ACHARIUS SL, THALLUS) (16-18:1); EXTRAGEN: WATER PURIFIED; MANUFACTURER KRKA, D.D., NOVO MESTO (BATCH CONTROL AND BATCH RELEASE) / KRKA, D.D., NOVO MESTO (""IN BULK"" PRODUCTION, PRIMARY AND SECONDARY PACKAGING), SLOVENIA/NLZOH (NATIONAL LABORATORY FOR HEALTH, ENVIRONMENT AND HRANO) (SERIES CONTROL), SLOVENIA | |
|
EUROPEAN UNION | UKRAINE | 0 |
| 2106909890 | 1. DRUG INTENDED TO IMPROVE WELL-BEING FOR COUGH AND COLD DISEASES, REGISTERED AS MEDICINAL PRODUCTS FOR RETAIL TRADE, NOT IN AEROSOL PACKAGING: BILOBIL ® FORTE, 80 MG CAPSULES, 10 CAPSULES IN BLISTERS, 6 BLISTERS IN A CARDBOARD BOX / 1 THE CAPSULE CONTAINS A DRY GINKGO BILOBA LEAF EXTRACT (GINKGO BILOBA L., FOLIUM) (RATIO OF STARTING MATERIALS TO AN EXTRACT OF 35–67: 1) WITH THE CONTENT: - 17.6–21.6 MG OF FLAVONOIDS IN THE FORM OF FLAVONIC GLYCOSIDES; 2.72 MG GINKHOLIDES A, B, C; – 2.08–2.56 MG BILOBALIDIVE – 80 MG; EXTRACTANT – ACETONE; MANUFACTURER KRKA, D.D., NOVO MESTO (“IN BULK” PRODUCTION, PRIMARY AND SECONDARY PACKAGING , SERIES CONTROL AND RELEASE) / KRKA, D.D., NOVO MESTO (SERIES CONTROL), SLOVENIA | |
|
EUROPEAN UNION | UKRAINE | 0 |
| 2106909200 | 1. DIETARY SUPPLEMENTS FOR HUMANS (BIOLOGICALLY ACTIVE FOOD SUPPLEMENTS) THAT DO NOT CONTAIN ALCOHOL, COMPONENTS OF ANIMAL ORIGIN, WITHOUT DAIRY FATS, SUCROSE, ISOGLUCOSE, GLUCOSE, STARCH, NOT IN AEROSOL PACKAGING: HERBION® SYRUP ICELAND MOSS, SYRUP, 6 MG/ML OF 150 ML IN A VIAL; 1 VIAL WITH MEASURING SPOON IN A CARDBOARD BOX / 1 ML OF SYRUP CONTAINS 6 MG OF THICK EXTRACT OF ICELAND MOSS (CETRARIA ISLANDICA (L.) ACHARIUS SL, THALLUS) (16-18:1); EXTRAGEN: WATER PURIFIED; MANUFACTURER KRKA, D.D., NOVO MESTO (BATCH CONTROL AND BATCH RELEASE) / KRKA, D.D., NOVO MESTO (""IN BULK"" PRODUCTION, PRIMARY AND SECONDARY PACKAGING), SLOVENIA/NLZOH (NATIONAL LABORATORY FOR HEALTH, ENVIRONMENT AND HRANO) (SERIES CONTROL), SLOVENIA | |
|
EUROPEAN UNION | UKRAINE | 0 |
| 2106909890 | 1. DRUG INTENDED TO IMPROVE WELL-BEING FOR COUGH AND COLD DISEASES, REGISTERED AS MEDICINAL PRODUCTS FOR RETAIL TRADE, NOT IN AEROSOL PACKAGING: BILOBIL ® FORTE, 80 MG CAPSULES, 10 CAPSULES IN BLISTERS, 6 BLISTERS IN A CARDBOARD BOX / 1 THE CAPSULE CONTAINS A DRY GINKGO BILOBA LEAF EXTRACT (GINKGO BILOBA L., FOLIUM) (RATIO OF STARTING MATERIALS TO AN EXTRACT OF 35–67: 1) WITH THE CONTENT: - 17.6–21.6 MG OF FLAVONOIDS IN THE FORM OF FLAVONIC GLYCOSIDES; 2.72 MG GINKHOLIDES A, B, C; – 2.08–2.56 MG BILOBALIDIVE – 80 MG; EXTRACTANT – ACETONE; MANUFACTURER KRKA, D.D., NOVO MESTO (“IN BULK” PRODUCTION, PRIMARY AND SECONDARY PACKAGING , SERIES CONTROL AND RELEASE) / KRKA, D.D., NOVO MESTO (SERIES CONTROL), SLOVENIA | |
|
EUROPEAN UNION | UKRAINE | 0 |
| 3004200000 | 1. DRUGS FOR HUMANS CONTAINING ANTIBIOTICS, FOR RETAIL TRADE, NOT IN AEROSOL PACKAGING: FROMILID ® UNO, MODIFIED-RELEASE TABLETS 500 MG 7 TABLETS IN BLISTERS; 1 BLISTER IN A CARDBOARD BOX / 1 TABLET CONTAINS 500 MG OF CLARITROMYCIN; MANUFACTURER KRKA, D.D., NOVO MESO, SLOVENIA; FROMILID ®, FILM-COATED TABLETS, 500 MG, 7 TABLETS IN A BLISTER; 2 BLISTERS IN A CARDBOARD BOX / 1 FILM-COATED TABLET CONTAINS 500 MG OF CLARITROMYCIN; MANUFACTURER KRKA, D.D., NOVO MESTO (MANUFACTURING """"IN BULK"""", PRIMARY AND SECONDARY PACKAGING, BATCH CONTROL AND BATCH RELEASE) / KRKA, D.D., NOVO MESTO (BATCH CONTROL), SLOVENIA | |
|
SLOVENIA | UKRAINE | 0 |
| 3004320000 | 1. MEDICINES FOR HUMANS CONTAINING CORTICOSTEROID HORMONES, PACKAGED FOR RETAIL, NOT IN AEROSOLS: DEXAMETHASONE, SOLUTION FOR INJECTION, 4 MG/ML, 1 ML IN AMPOULE; 5 AMPOULES IN BLISTERS; 5 BLISTERS IN A CARDBOARD BOX / 1 ML OF SOLUTION FOR INJECTION CONTAINS 4 MG OF DEXAMETHASONE PHOSPHATE AS DEXAMETHASONE SODIUM PHOSPHATE; MANUFACTURER KRKA, D.D., NOVO MESTO (MANUFACTURING """"IN BULK"""", PRIMARY AND SECONDARY PACKAGING, BATCH CONTROL AND RELEASE) / KRKA, D.D., NOVO MESTO (BATCH CONTROL), SLOVENIA/NLZOH (NATIONAL LABORATORY FOR HEALTH, THE ENVIRONMENT AND HRANO) (LOT CONTROL), SLOVENIA; DEXAMETHASONE, TABLETS OF 0.5 MG, 10 TABLETS IN A BLISTER; 1 BLISTERS IN A CARDBOARD BOX / 1 TABLET CONTAINS 0.5 MG OF DEXAMETHASONE; MANUFACTURER KRKA, D.D., NOVO MESTO (MANUFACTURER RESPONSIBLE FOR ""IN BULK"" PRODUCTION, PRIMARY AND SECONDARY PACKAGING, CONTROL AND BATCH RELEASE) / KRKA, D.D., NOVO MESTO (MANUFACTURER RESPONSIBLE FOR PRIMARY AND SECONDARY PACKAGING) / KRKA, D.D., NOVO MESTO (MANUFACTURER RESPONSIBLE FOR BATCH CONTROL), SLOVENIA; DEXAMETHASONE KRKA, 20 MG TABLETS, 10 TABLETS IN BLISTERS; 1 BLISTER IN A CARDBOARD BOX / 1 TABLET CONTAINS 20 MG OF DEXAMETHASONE; MANUFACTURER KRKA, D.D., NOVO MESTO (""IN BULK"" MANUFACTURING, PRIMARY AND SECONDARY PACKAGING, BATCH CONTROL AND RELEASE) / KRKA, D.D., NOVO MESTO (PRIMARY AND SECONDARY PACKAGING) / KRKA, D.D. , NOVO MESTO (SERIES CONTROL), SLOVENIA | |
|
SLOVENIA | UKRAINE | 0 |
| 3004900000 | 1. DRUGS FOR HUMANS, WITHOUT CONTENT: VITAMINS, HORMONES, ALKALOIDS, ANTIBIOTICS, FOR RETAIL TRADE, NOT IN AEROSOL PACKAGING: CAPTOPRIL, 12.5 MG TABLETS, 10 TABLETS IN A BLISTER; 2 BLISTERS IN A CARDBOARD BOX / 1 TABLET CONTAINS 12.5 MG CAPTOPRIL; MANUFACTURER KRKA, D.D., NOVO MESTO (RESPONSIBLE FOR ""IN BULK"" PRODUCTION, PRIMARY AND SECONDARY PACKAGING, CONTROL AND BATCH RELEASE), SLOVENIA; CAPTOPRIL, 25 MG TABLETS, 10 TABLETS IN BLISTERS; 2 BLISTERS IN A CARDBOARD BOX / 1 TABLET CONTAINS 25 MG CAPTOPRIL; MANUFACTURER KRKA, D.D., NOVO MESO (RESPONSIBLE FOR ""IN BULK"" PRODUCTION, PRIMARY AND SECONDARY PACKAGING, CONTROL AND BATCH RELEASE), SLOVENIA; CAPTOPRIL, 50 MG TABLETS, 10 TABLETS IN BLISTERS; 2 BLISTERS IN A CARDBOARD BOX / 1 TABLET CONTAINS 50 MG CAPTOPRIL; MANUFACTURER KRKA, D.D., NOVO MESTO (RESPONSIBLE FOR ""IN BULK"" PRODUCTION, PRIMARY AND SECONDARY PACKAGING, CONTROL AND BATCH RELEASE), SLOVENIA/KRKA, D.D., NOVO MESTO (RESPONSIBLE FOR PRIMARY AND SECONDARY PACKAGING), SLOVENIA; KORIOL ®, TABLETS OF 3.125 MG, 7 TABLETS IN A BLISTER, 4 BLISTERS IN A CARDBOARD BOX / 1 TABLET CONTAINS 3.125 MG OF CARVEDILOL; MANUFACTURER KRKA, D.D., NOVO MESO (MANUFACTURING """"IN BULK"""", PRIMARY AND SECONDARY PACKAGING, BATCH CONTROL AND BATCH RELEASE), SLOVENIA/KRKA, D.D., NOVO MESTO (BATCH CONTROL), SLOVENIA; KORIOL ®, TABLETS OF 6.25 MG, 7 TABLETS IN A BLISTER, 4 BLISTERS IN A CARDBOARD BOX / 1 TABLET CONTAINS 6.25 MG OF CARVEDILOL; MANUFACTURER KRKA, D.D., NOVO MESO (MANUFACTURING """"IN BULK"""", PRIMARY AND SECONDARY PACKAGING, BATCH CONTROL AND BATCH RELEASE), SLOVENIA/KRKA, D.D., NOVO MESTO (BATCH CONTROL), SLOVENIA; KORIOL ®, 25 MG TABLETS, 14 TABLETS IN BLISTERS; 2 BLISTERS IN A CARDBOARD BOX / 1 TABLET CONTAINS CARVEDILOL 25 MG; MANUFACTURER KRKA, D.D., NOVO MESTO (MANUFACTURING """"IN BULK"""", PRIMARY AND SECONDARY PACKAGING, BATCH CONTROL AND BATCH RELEASE), SLOVENIA/KRKA, D.D., NOVO MESTO (BATCH CONTROL), SLOVENIA; LEVAKSELA ®, FILM-COATED TABLETS OF 500 MG; 7 TABLETS IN BLISTERS; 1 BLISTER IN A CARDBOARD BOX / 1 TABLET CONTAINS LEVOFLOXACIN 500 MG AS LEVOFLOXACIN HEMIHYDRATE; MANUFACTURER KRKA, D.D., NOVO MESTO (PRIMARY AND SECONDARY PACKAGING, BATCH CONTROL AND BATCH RELEASE), SLOVENIA/KRKA, D.D., NOVO MESTO (""IN BULK"" MANUFACTURE, PRIMARY AND SECONDARY PACKAGING), SLOVENIA /KRKA, D.D., NOVO MESO (LOT CONTROL), SLOVENIA; LORISTA ®, FILM-COATED TABLETS, 50 MG, 10 TABLETS IN BLISTERS; 9 BLISTERS IN A CARDBOARD BOX / 1 FILM-COATED TABLET CONTAINS 50 MG OF LOSARTAN POTASSIUM; MANUFACTURER KRKA, D.D., NOVO MESTO (MANUFACTURER RESPONSIBLE FOR ""IN BULK"" PRODUCTION, PRIMARY AND SECONDARY PACKAGING, BATCH CONTROL AND RELEASE)/KRKA, D.D., NOVO MESTO (MANUFACTURER RESPONSIBLE FOR BATCH CONTROL), SLOVENIA/TAD FARMA GMBH (MANUFACTURER RESPONSIBLE FOR PRIMARY AND SECONDARY PACKAGING AND BATCH RELEASE), GERMANY/LABENA D.O.O. (MANUFACTURER RESPONSIBLE FOR BATCH CONTROL), SLOVENIA/LABOR L+S AG (MANUFACTURER RESPONSIBLE FOR BATCH CONTROL) CROBIOLOGICAL BATCH PURITY ( IN THE CASE OF TAD PHARMA GMBH BATCH CONTROL), GERMANY/NINGBO TIANKANG PHARMACEUTICALS CO., LTD (MANUFACTURER RESPONSIBLE FOR ""IN BULK"" PRODUCTION), CHINA; LORISTA ® FILM-COATED TABLETS , PO 100 MG, 10 TABLETS IN BLISTERS; 3 BLISTERS IN A CARDBOARD BOX / 1 FILM-COATED TABLET CONTAINS 100 MG OF LOSARTAN POTASSIUM; MANUFACTURER KRKA, D.D., NOVO MESTO (MANUFACTURER RESPONSIBLE FOR ""IN BULK"" PRODUCTION, PRIMARY AND SECONDARY PACKAGING, BATCH CONTROL AND RELEASE)/KRKA, D.D., NOVO MESTO (MANUFACTURER RESPONSIBLE FOR BATCH CONTROL), SLOVENIA/TAD FARMA GMBH (MANUFACTURER RESPONSIBLE FOR PRIMARY AND SECONDARY PACKAGING AND BATCH RELEASE), GERMANY/LABENA D.O.O. (MANUFACTURER RESPONSIBLE FOR BATCH CONTROL), SLOVENIA/LABOR L+S AG (MANUFACTURER RESPONSIBLE FOR BATCH CONTROL) CROBIOLOGICAL BATCH PURITY (IN CASE OF BATCH CONTROL TAD PHARMA GMBH)), GERMANY/NINGBO I.E. TIANKANG PHARMACY | |
|
SLOVENIA | UKRAINE | 0 |
| 2106909200 | 1. DIETARY SUPPLEMENTS FOR HUMANS (BIOLOGICALLY ACTIVE FOOD SUPPLEMENTS). COMPOSITE PRODUCTS THAT MEET THE CONDITIONS DETERMINED BY PART ELEVENTH ARTICLE 41 OF THE LAW OF UKRAINE ""ON STATE CONTROL OF COMPLIANCE WITH THE LEGISLATION ON ARCH PRODUCTS, ANIMAL BY-PRODUCTS, ANIMAL HEALTH AND WELFARE"" "",CONSUMER PACKAGED DIETARY SUPPLEMENTS,NON-GMO:""""DUOVIT ® FOR MEN""""(""""DUOVIT ® FOR MEN""""), VITAMINS AND MINERALS 30 TABLETS IN VIALS MADE OF POLYMER MATERIAL IN CARDBOARD BOXES/TOCOPHEROL ACETATE, ASCORBIN K-TA, NIACIN, CALCIUM PANTOTHENATE, VITAMIN A ACETATE, CYANOCOBALAMIN, BIOTIN, CHOLECALCIPHEROL, PYRIDOXINE HYDROCHLORIDE, FOLIV K-TA, RIBOFLAVIN, IRON FUMARATE, ZINC OXIDE, COPPER GLUCONATE, MANGANESE B SULFATE MONOHYDRATE, POTASSIUM IODIDE, MAGNESIUM OXIDE/(WEIGHT OF 1 TABLET 1030MG) / TOCOPHEROL ACETATE 50%-98.34MG (VITAMIN E-30MG), ASCORBIC ACID-63.00MG (VITAMIN C-60MG), NIACIN-21.0MG (VITAMIN RR-20MG), CALCIUM PANTOTHENATE-9.32MG (PANTOTHENIC ACID-6.4MG), VITAMIN A ACETATE-8.33MG (VITAMIN A-1000MG), CYANOCOBALAMIN 0.1%-6.9MG (VITAMIN B12-6.0MG), BIOTIN 1% -4.2MG (BIOTIN 30MG), CHOLECALCIFEROL-2.8MG (VITAMIN D-5MG), PYRIDOXINE HYDROCHLORIDE-2.8MG (VITAMIN B6-2.0MG), FOLIC ACID 10%-2.4MG (FOLIC ACID-200MG) ,THIAMINE MONOHYDRATE 2.22MG (VITAMIN B1-1.5MG),RIBOFLAVIN-2.21MG(VITAMIN B2-1.7MG),IRON FUMARATE-31.73MG(IRON-10MG),ZINC OXIDE-18.67MG(ZINC- 15MG), COPPER GLUCONATE-14.3MG (COPPER-2MG), MANGANESE SULFATE MONOHYDRATE-10.77MG (MANGANESE-3.5MG), POTASSIUM IODIDE 10%-2.63MG (IODE-150MG); MANUFACTURER KRKA, D.D. ., NOVO MESO, SLOVENIA | |
|
EUROPEAN UNION | UKRAINE | 0 |
| 3004200000 | 1. DRUGS FOR HUMANS CONTAINING ANTIBIOTICS, FOR RETAIL SALE, NOT IN AEROSOL PACKAGING: MACROPEN ® FILM-COATED TABLETS, 400 MG, 8 TABLETS IN BLISTERS; 2 BLISTERS IN A CARDBOARD BOX / 1 FILM-COATED TABLET CONTAINS 400 MG OF MIDECAMYCIN; MANUFACTURER KRKA, D.D., NOVO MESTO (MANUFACTURER RESPONSIBLE FOR PRODUCTION, PRIMARY AND SECONDARY PACKAGING, QUALITY CONTROL AND BATCH RELEASE), SLOVENIA/P&G HELS AUSTRIA GMBH & CO. OG (MANUFACTURER RESPONSIBLE FOR PRODUCTION, PRIMARY AND SECONDARY PACKAGING, QUALITY CONTROL), AUSTRIA | |
|
AUSTRIA | UKRAINE | 0 |
| 3004200000 | 1. MEDICINE FOR HUMANS CONTAINING ANTIBIOTICS, NOT IN AEROSOLS: FROMILIDE ® GRANULES FOR PREPARATION OF ORAL SUSPENSION 60ML (250MG/5ML), 1 VIAL WITH GRANULES AND 1 SPRAY Ц FOR ORAL ADMINISTRATION OF SUSPENSION IN A CARTON BOX / 5 ML OF SUSPENSION (1 SYRINGE) CONTAINS 250 MG OF CLARITROMYCIN; MANUFACTURER KRKA, D.D., NOVO MESTO (SECONDARY PACKAGING, BATCH CONTROL AND BATCH RELEASE) / KRKA, D.D., NOVO MESTO (""IN BULK"" PRODUCTION, PRIMARY AND SECONDARY PACKAGING) / KRKA, D.D | |
|
SLOVENIA | UKRAINE | 0 |
| 3004320000 | 1. DRUGS FOR HUMANS CONTAINING CORTICOSTEROID HORMONES, PACKAGED FOR RETAIL TRADE, NOT IN AEROSOL PACKAGING KENALOG 40, SUSPENSION FOR INJECTION, 40 MG/ML, 1 ML IN AMPOULE; 5 AMPOULES IN BLISTERS; 1 BLISTER IN A CARDBOARD BOX / 1 ML OF SUSPENSION FOR INJECTION CONTAINS TRIAMCINOLON ACETONIDE 40 MG; MANUFACTURER KRKA, D.D., NOVO MESO, SLOVENIA | |
|
SLOVENIA | UKRAINE | 0 |
| 3004900000 | 1. DRUGS FOR HUMANS, WITHOUT CONTENT: VITAMINS, HORMONES, ALKALOIDS, ANTIBIOTICS, FOR RETAIL TRADE, NOT IN AEROSOL PACKAGING: AMLESSA, TABLETS, 4 MG/5 MG OF 10 TABLETS IN BLISTERS; 3 BLISTERS IN A CARDBOARD BOX / 1 TABLET CONTAINS 4 MG PERINDOPRIL TERT-BUTYLAMINE (EQUIVALENT TO 3.34 MG PERINDOPRIL) AND 5 MG AMLODIPINE (EQUIVALENT TO 6.935 MG AMLODIPINE BESYLATE); MANUFACTURER KRKA, D.D., NOVO MESO (MANUFACTURING """"IN BULK"""", PRIMARY AND SECONDARY PACKAGING, BATCH CONTROL AND RELEASE), SLOVENIA/KRKA, D.D., NOVO MESO (BATCH CONTROL (PHYSICAL AND CHEMICAL CONTROL METHODS )), SLOVENIA; AMLESSA, TABLETS, 4 MG/10 MG 10 TABLETS IN BLISTERS; 3 BLISTERS IN A CARDBOARD BOX / 1 TABLET CONTAINS 4 MG PERINDOPRIL TERT-BUTYLAMINE (EQUIVALENT TO 3.34 MG PERINDOPRIL) AND 10 MG AMLODIPINE (EQUIVALENT TO 13.870 MG AMLODIPINE BESYLATE); MANUFACTURER KRKA, D.D., NOVO MESO (MANUFACTURING """"IN BULK"""", PRIMARY AND SECONDARY PACKAGING, BATCH CONTROL AND RELEASE), SLOVENIA/KRKA, D.D., NOVO MESO (BATCH CONTROL (PHYSICAL AND CHEMICAL CONTROL METHODS )), SLOVENIA; CO-AMLESSA, TABLETS, 4 MG/1.25 MG/5 MG 10 TABLETS IN BLISTERS; 3 BLISTERS IN A CARDBOARD BOX / 1 TABLET CONTAINS: 4 MG OF PERINDOPRIL TERT-BUTYLAMINE, 1.25 MG OF INDAPAMIDE AND 5 MG OF AMLODIPINE (AS AMLODIPINE BESYLATE); MANUFACTURER KRKA, D.D., NOVO MESTO (MANUFACTURING """"IN BULK"""", PRIMARY AND SECONDARY PACKAGING, BATCH CONTROL, BATCH RELEASE)/KRKA, D.D., NOVO MESTO (PRIMARY AND SECONDARY PACKAGING)/KRKA, D .D., NOWO MESO (SERIES CONTROL), SLOVENIA/KRKA, POLAND SP.Z.O.O. (PRIMARY AND SECONDARY PACKAGING, BATCH CONTROL, BATCH RELEASE), POLAND/TAD PHARMA GMBH (PRIMARY AND SECONDARY PACKAGING, BATCH CONTROL, BATCH RELEASE), GERMANY/LS CE & CO. LABORATORY. KG (CONTROL OF MICROBIOLOGICAL PURITY OF THE SERIES (IN THE CASE OF SERIES CONTROL OF TAD PHARMA GMBH)), GERMANY; KO-AMLESSA, TABLETS, 8 MG/2.5 MG/5 MG 10 TABLETS IN BLISTERS; 3 BLISTERS IN A CARDBOARD BOX / 1 TABLET CONTAINS: 8 MG PERINDOPRIL TERT-BUTYLAMINE, 2.5 MG INDAPAMIDE AND 5 MG AMLODIPINE (AS AMLODIPINE BESYLATE); MANUFACTURER KRKA, D.D., NOVO MESTO (MANUFACTURING """"IN BULK"""", PRIMARY AND SECONDARY PACKAGING, BATCH CONTROL, BATCH RELEASE)/KRKA, D.D., NOVO MESTO (PRIMARY AND SECONDARY PACKAGING)/KRKA, D .D., NOWO MESO (SERIES CONTROL), SLOVENIA/KRKA, POLAND SP.Z.O.O. (PRIMARY AND SECONDARY PACKAGING, BATCH CONTROL, BATCH RELEASE), POLAND/TAD PHARMA GMBH (PRIMARY AND SECONDARY PACKAGING, BATCH CONTROL, BATCH RELEASE), GERMANY/LS CE & CO. LABORATORY. KG (CONTROL OF MICROBIOLOGICAL PURITY OF THE SERIES (IN THE CASE OF SERIES CONTROL OF TAD PHARMA GMBH)), GERMANY; KO-AMLESSA, TABLETS, 8 MG/2.5 MG/10 MG OF 10 TABLETS IN BLISTERS; 3 BLISTERS IN A CARDBOARD BOX / 1 TABLET CONTAINS: 8 MG PERINDOPRIL TERT-BUTYLAMINE, 2.5 MG INDAPAMIDE AND 10 MG AMLODIPINE (AS AMLODIPINE BESYLATE); MANUFACTURER KRKA, D.D., NOVO MESTO (MANUFACTURING """"IN BULK"""", PRIMARY AND SECONDARY PACKAGING, BATCH CONTROL, BATCH RELEASE)/KRKA, D.D., NOVO MESTO (PRIMARY AND SECONDARY PACKAGING)/KRKA, D .D., NOWO MESO (SERIES CONTROL), SLOVENIA/KRKA, POLAND SP.Z.O.O. (PRIMARY AND SECONDARY PACKAGING, BATCH CONTROL, BATCH RELEASE), POLAND/TAD PHARMA GMBH (PRIMARY AND SECONDARY PACKAGING, BATCH CONTROL, BATCH RELEASE), GERMANY/LS CE & CO. LABORATORY. KG (CONTROL OF MICROBIOLOGICAL PURITY OF THE SERIES (IN THE CASE OF SERIES CONTROL OF TAD PHARMA GMBH)), GERMANY; AMPRIL ® HD, TABLETS OF 5 MG/25 MG, 10 TABLETS IN A BLISTER, 3 BLISTERS IN A CARDBOARD BOX / CONTAINS 1 TABLET 5 MG RAMIPRIL TA 25 MG HYDROCHLOROTHIAZIDE; MANUFACTURER KRKA, D.D., NOVO MESTO (MANUFACTURING """"IN BULK"""", PRIMARY AND SECONDARY PACKAGING, CONTROL AND BATCH RELEASE), SLOVENIA/KRKA, D.D., NOVO MESTO (""MANUFACTURING """"IN BULK"")"", SLOVENIA AMPRIL ®, 2.5 MG TABLETS 10 TABLETS IN A BLISTER, 3 BLISTERS IN A CARDBOARD BOX / 1 TABLET CONTAINS RAMIPRIL 2.5 MG; MANUFACTURER KRKA, D.D., NOVO MESTO (RESPONSIBLE FOR """"IN BULK"""" PRODUCTION, PRIMARY AND SECONDARY PACKAGING, BATCH CONTROL AND BATCH RELEASE), SLOVENIA/KRKA, D.D., NOVO MESTO (RESPONSIBLE FOR """"MANUFACTURING"" IN BULK"", PRIMARY AND WT | |
|
SLOVENIA | UKRAINE | 0 |
Get Started with Eximpedia
Start 5 Days Free Trial
No Pay, No Delay - 5 days Your Way!
Book a Free Demo
Learn How our platform works in just 20 minutes!
Download Free Sample Report
Free Import-Export Sample data-One Click Away!
Why should you choose Eximpedia?
Broad Range of Country Datasets
Our dedicated team of experts delivers current and flexible data from key global locations, enabling you to make essential decisions with vital information and insights.
Easy to understand deep analysis
We use bespoke layered visualizations for diving deep into our country and logistics data to provide your team with graphical assistance and essential data analysis and reporting.
Most Accurate Information
All of our datasets are quality-controlled by layers of inspection before it ever reach your platform. This helps us maintain the high reliability our clients have come to trust.
Competitive Supplier Engagement Watch
Keep an eye out for any collaboration between your suppliers and your rivals, as this may impact their ability to satisfy your requirements.
Right away on-screen support
With instant remote on-screen assistance, chat support, and user training, our customer success team is available to you around the clock.
Access Database Across 130+ Countries
Explore competitors' shipment histories, statistical and analytical reports, and country-specific information from more than 130 nations.
Badm Limited Liability Company frequently asked questions
You can explore detailed shipment records of Badm Limited Liability Company through Eximpedia’s real-time trade insights platform, which provides access to shipment dates, quantities, ports, and product details.
Yes, Eximpedia offers a directory of buyers with similar trade patterns to Badm Limited Liability Company. Use advanced filters to identify competitors or partners in the same industry.
With our data-driven platform, you can access a curated list of suppliers with comparable product categories and shipment volumes to Badm Limited Liability Company, helping you expand your sourcing network.
Eximpedia’s trade data highlights Badm Limited Liability Company’s major exports, along with their trade destinations and origins.
We provide detailed analytics, including trade volumes, market trends, port usage, and competitor insights, to help businesses understand Badm Limited Liability Company’s trade activities.
Traders can collaborate with Badm Limited Liability Company by contacting them through their official channels or visiting their headquarters for detailed trade discussions.